The FDA recently published a drug trials Snapshot on Wakix for narcolepsy, which highlights who participated in the clinical trials that supported the FDA approval of this drug, and whether there were differences among sex, race and age groups.

  • Sex: WAKIX worked similarly in men and women.
  • Race: The majority of patients were White. The number of patients of other races was limited; therefore, differences in how well WAKIX worked among races could not be determined.
  • Age: The majority of patients were adults less than 65 years of age. The number of patients older than 65 years of age was limited; therefore, differences in how well WAKIX worked between patients younger and older than 65 years of age could not be determined.